Related Experiment Video
Updated: Aug 10, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
The anti-hypertensive effects of exercise: integrating acute and chronic mechanisms
1Department of Epidemiology and Public Health, University College London, London, England. m.hamer@ucl.ac.uk
Abstract:
It is anticipated that hypertension will afflict up to a third of the worldwide population by the year 2025. Therefore, cost-effective treatment strategies are essential to control this disease. Exercise has been associated with anti-hypertensive benefits, but despite extensive research the optimal exercise dose (training frequency, intensity and time) required to lower blood pressure and maintain normotensive status remains unclear. This article explores the interrelationships between acute and chronic mechanisms that have been linked to the anti-hypertensive benefits of exercise and proposes that the optimal exercise dosage may depend on the interplay between these mechanisms and the effects of exercise on independent risk markers of hypertension. Therefore, the correct exercise dose for the treatment of hypertension should be prescribed on an individual basis. Future work should examine post-exercise hypotension effects in relation to exercise training in hypertensive populations and both acute and longitudinal training studies should be conducted that incorporate independent risk factors of hypertension as co-variables into their analysis on blood pressure effects.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
05:57The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology